What are Humira and Remicade?
Abbot Laboratories’ Humira and Centocor’s Remicade are medications used to treat rheumatoid arthritis , an autoimmune condition affecting more than two million Americans, which causes painful, joint inflammation and deformity. Humira and Remicade belong to a class of TNF-blocking (tumor necrosis factor) drugs , which block the inflammatory process in the body reducing pain and increasing flexibility, range of motion, and life expectancy. Remicade was approved by the U.S. Food and Drug Administration in 1998, and Humira was approved in 2002 for the treatment of rheumatoid arthritis as well as Crohn’s disease, an inflammatory bowel condition. Currently, an estimated 500,000 people in the United States have been prescribed these medications. Other Risks Linked to Humira and Remicade The new Mayo Clinic study is not the first report linking Humira and Remicade to serious adverse side effects , but it is the only one to quantify the dangers as well as discover further types of cancer associ